Oxford, United Kingdom

James Graham

This inventor holds 1 USPTO granted patent. Top assignee: Lonza Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Graham. Retrieved from https://idiyas.com/inventor/james-graham-kmbm5nol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of James Graham

Introduction

James Graham is an accomplished inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of eukaryotic host cells for protein production. His innovative work has the potential to enhance the efficiency of producing proteins of interest.

Latest Patents

James Graham holds a patent for a "Host cell for producing a protein of interest." This invention involves a genetically modified eukaryotic host cell designed to produce a heterologous protein of interest (POI). The cell is engineered to reduce the production of at least one of three different endogenous host cell proteins (HCP), thereby improving the yield of the desired protein.

Career Highlights

James is currently employed at Lonza Inc., a leading global provider of integrated solutions for the pharmaceutical and biotechnology industries. His role at Lonza allows him to apply his expertise in protein production and contribute to advancements in biopharmaceutical manufacturing.

Collaborations

Throughout his career, James has collaborated with notable colleagues, including Christoph Kiziak and Katrien Claes. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

James Graham's work exemplifies the impact of innovative thinking in biotechnology. His patent and contributions to protein production highlight the importance of advancements in this field. His collaborations further enhance the potential for future breakthroughs in biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…